virginiamycin and Enteritis

The effects of increasing aflatoxin B1 concentration (0, 0.75, 1.5 mg/kg) on broilers with or without necrotic enteritis or virginiamycin were determined. In the 23-d study, 22 male Cobb 500 chicks per pen were allotted to 12 treatments (3 × 2 × 2 factorial arrangement) with 8 replications. Intestines of 5 birds per pen were examined for lesions on d 21. Birds were allowed to consume feed and water ad libitum. Aflatoxin was included in the diets from d 0. All birds received a 10× dose of coccidiosis vaccine on d 10. Pens of birds where necrotic enteritis was being induced were on Clostridium perfringens pathogen (CPP) contaminated litter from d 0. Aflatoxin decreased gain and feed intake and resulted in poorer feed:gain, increased mortality, and higher lesion scores. Inducing necrotic enteritis increased lesion scores and decreased feed intake and gain. Adding virginiamycin to the diets improved gain, feed intake, feed conversion, and decreased mortality. There was a 3-way interaction (aflatoxin × virginiamycin × CPP) on gain; increasing aflatoxin decreased gain and the effects of CPP and virginiamycin were dependent on aflatoxin concentration. In the absence of aflatoxin virginiamycin increased gain but was unable to prevent the growth suppression caused by CPP. At 0.75 mg/kg of aflatoxin virginiamycin no longer increased growth in non-CPP challenged birds but was able to increase growth in CPP-challenged birds. At the 1.5 mg/kg of aflatoxin concentration, virginiamycin increased gain in non-CPP-challenged birds but challenging birds with CPP had no effect on gain. Virginiamycin improved overall feed conversion with the greatest improvement at 1.5 mg/kg (aflatoxin × virginiamycin, P < 0.05). Aflatoxin increased lesion scores in unchallenged birds but not in challenged birds (aflatoxin × CPP, P < 0.001). Aflatoxin and necrotic enteritis decrease broiler performance and interact to decrease weight gain, virginiamycin helps improve gain in challenged birds at 0.75 mg/kg of aflatoxin, but not at 1.5 mg/kg of aflatoxin.

Topics: Aflatoxin B1; Aging; Animal Feed; Animals; Chickens; Eating; Enteritis; Male; Poultry Diseases; Virginiamycin

Two experiments were conducted to evaluate the effect of virginiamycin (VM, 22 mg/kg of diet) on performance of uninfected (CON) turkey poults and those infected (INO) with stunting syndrome and reared on used woodshavings (Experiment 1) or on clean or used woodshavings (Experiment 2). Virginiamycin improved BW (P less than .001) and feed efficiency (FE) (P less than .05) from 1 to 29 days of age, irrespective of type of litter or disease condition. The increase in BW induced by VM, however, was greatest when poults were kept on used litter, resulting in significant (P less than .05) VM by litter interaction. Induced stunting syndrome depressed BW (P less than .01) to 29 days of age and impaired FE from 1 to 9 days of age (P less than .05) and from 5 to 9 days of age (P less than .01) in Experiments 1 and 2, respectively. Virginiamycin did not prevent early adverse effects of INO on BW and FE, but facilitated notable recovery of INO poults relative to INO poults not fed VM. Virginiamycin increased specific activities of maltase and sucrase of the jejunum of CON poults in Experiments 1 and 2; in Experiment 2, this VM effect was evident irrespective of type of litter. Maltase-specific activity and sucrase were reduced by INO (P less than or equal to .05 and P less than or equal to .01 in Experiments 1 and 2, respectively) and VM did not modify this effect. The maltase and sucrase data suggest that VM improved BW and FE of CON poults, in part, by helping to maintain digestive and absorptive functions of the small intestine during the early growth period, but, in the instance of INO poults, VM was not effective in this regard.

Topics: alpha-Glucosidases; Animals; Body Weight; Digestion; Enteritis; Growth Disorders; Jejunum; Male; Poultry Diseases; Sucrase; Syndrome; Turkeys; Virginiamycin

Duplicate trials were conducted with male broiler chickens to evaluate virginiamycin as treatment against experimentally induced necrotic enteritis infection. Each trial consisted of seven treatments, each replicated four times, with 10 birds per replicate. Two treatments were fed control ration (noninfected control and infected control) and the five remaining treatments were fed virginiamycin at 5, 10, 15, 20, or 40 g/ton. Birds were orally dosed with 10 ml of Clostridium perfringens culture at 14 days of age. At 5 weeks of age, surviving birds were killed and necropsied to obtain lesion scores. Birds fed virginiamycin had significantly less mortality and lower intestinal lesion scores than nonmedicated birds when experimentally infected with necrotic enteritis.

Topics: Animals; Chickens; Clostridium Infections; Diet; Enteritis; Male; Poultry Diseases; Virginiamycin